Number of the records: 1
varianty farmakogenomické
SYS d000071184 LBL 00000nz--a2200181n--4500 005 20250606222054.0 008 170101|||anznnbabn-----------|-a|a------ 040 $b slo $a BA006 $d BA006 065 $a G05.365.795.446 066 $a 01 $c 03 150 $a varianty farmakogenomické $x DE $x GE $x IM $x PH $x RE $2 slo 450 $w v $a varianty farmakogenetické $2 slo 450 $w v $a varianty farmakokinetické genetické $2 slo 450 $w v $a varianty farmakokinetiky, genetické $2 slo 550 $7 sllk_us_auth*d010597 $Y Pharmacogenetics $w b $a farmakogenetika 550 $7 sllk_us_auth*d057285 $Y Precision Medicine $w b $a medicína personalizovaná 550 $7 sllk_us_auth*d010597 $Y Pharmacogenetics $w p $a farmakogenetika 550 $7 sllk_us_auth*d057285 $Y Precision Medicine $w p $a medicína personalizovaná 665 $a 2017 $2 eng 665 $a Genetic Variation (1968-2016) $2 eng 665 $a Pharmacogenetics (1968-2016) $2 eng 665 $a Polymorphism, Genetic (1980-2016) $2 eng 680 9-
$i Naturally occurring genetic variations associated with drug response (e.g., dosage, extent and rate of metabolic processes). While these variants are not markers for GENETIC PREDISPOSITION TO DISEASE they influence PHARMACOKINETICS and pharmacodynamics and often occur on genes encoding drug metabolism enzymes and transporters (e.g., ANGIOTENSIN CONVERTING ENZYME; CYTOCHROME P-450 CYP2D6). $2 eng 750 -2
$a Pharmacogenomic Variants $2 eng 980 $x M
Number of the records: 1